Short Interest in Global X HealthTech ETF (NASDAQ:HEAL) Expands By 154.7%

Global X HealthTech ETF (NASDAQ:HEAL) was the target of a significant increase in short interest during the month of March. As of March 31st, there was short interest totaling 7,481 shares, an increase of 154.7% from the March 15th total of 2,937 shares. Based on an average daily volume of 12,603 shares, the short-interest ratio is currently 0.6 days. Currently, 0.7% of the shares of the stock are sold short.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. Glenmede Investment Management LP acquired a new stake in Global X HealthTech ETF in the 3rd quarter valued at $31,000. AE Wealth Management LLC bought a new position in shares of Global X HealthTech ETF during the third quarter valued at $34,000. Banque Cantonale Vaudoise bought a new position in shares of Global X HealthTech ETF during the third quarter valued at $37,000. EverSource Wealth Advisors LLC lifted its holdings in shares of Global X HealthTech ETF by 26,522.2% during the fourth quarter. EverSource Wealth Advisors LLC now owns 2,396 shares of the company’s stock valued at $70,000 after acquiring an additional 2,387 shares during the period. Finally, Farther Finance Advisors LLC bought a new position in shares of Global X HealthTech ETF during the fourth quarter valued at $111,000.

Global X HealthTech ETF Trading Down 0.9%

HEAL stock opened at $24.10 on Friday. The firm has a market capitalization of $24.10 million, a PE ratio of 42.80 and a beta of 1.17. Global X HealthTech ETF has a one year low of $23.00 and a one year high of $34.20. The firm has a 50-day moving average of $25.43 and a two-hundred day moving average of $29.05.

About Global X HealthTech ETF

An ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.